CLOSE X
GO

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
32.16 0.11(0.34%) NAV as on 30 Jul 2025
4.45 % 1 M
8.21 % 1 Y
23.39 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.32

As on 30 Jun, 2025
age-icon Age :

6 yrs 0 m

Since 10 07 ,2019
exit_load Exit Load :

1%

aum AUM :

840.48 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

9

Min_Investment Min. Investment :

SIP 100 & Lumpsum 1000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Dhaval Shah,Dhaval Joshi

LATEST ASSET & PORTFOLIO ALLOCATION

as on Jun 30 ,2025
Others 1.58 %
Equity 98.42 %

TOP HOLDINGS

Sun Pharmaceutical Industries...11.69 %
Cipla Ltd.7.65 %
Apollo Hospitals Enterprise Ltd.7.32 %
Abbott India Ltd.6.92 %
Torrent Pharmaceuticals Ltd.5.41 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs75.91
Hospital & Healthcare Services19.93
Business Support1.66
Chemicals0.92
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)16.1218.2216.3626.4529.39
Net Assets(Rs Crores) (as on 31-Mar-2025) 454.91 515.33 428.44 699.55 814.95
Scheme Returns(%)(Absolute)63.4912.40-10.2661.3810.03
B'mark Returns(%)(Absolute)NANANANANA
Category Rank55/7549/7570/7611/9032/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity32.160.11(0.34%)NAV As on 30 Jul, 202510-Jul-2019Inception Date840.48AUM In Cr.8.21%1Y23.39%3Y18.89%5Y21.26%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity41.470.07(0.17%)NAV As on 30 Jul, 202513-Jul-2018Inception Date5,727.59AUM In Cr.17.05%1Y29.50%3Y23.89%5Y22.35%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity444.965.06(1.15%)NAV As on 30 Jul, 202514-Jul-1999Inception Date3,849.24AUM In Cr.16.99%1Y28.30%3Y23.68%5Y16.41%Since Inception
Nippon India Pharma Fund(G)Very HighEquity536.811.25(0.23%)NAV As on 30 Jul, 202505-Jun-2004Inception Date8,569.15AUM In Cr.10.90%1Y24.95%3Y21.24%5Y20.71%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors